Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. LUCD
LUCD logo

LUCD

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

LUCD News

Family-Owned Dealership Sale Highlights Industry Consolidation Trends

2d agoCNBC

Lucid Diagnostics CEO to Participate in Healthcare Conference

Apr 09 2026PRnewswire

PAVmed Appoints New Executive to Drive Medical Device Development

Apr 02 2026PRnewswire

PAVmed Restructures Capital and Relaunches Product Line

Mar 30 2026PRnewswire

Lucid Diagnostics Reports Strong Q4 2025 Earnings and VA Contract Win

Mar 26 2026seekingalpha

Lucid Diagnostics Reports Q4 2025 Earnings Highlights

Mar 26 2026Yahoo Finance

Lucid Diagnostics Reports Q4 Highlights and Revenue Growth

Mar 26 2026PRnewswire

Lucid Diagnostics Q4 Earnings Report Analysis

Mar 26 2026seekingalpha

Citi Initiates Buy Rating on Lucid with $17 Price Target

Mar 19 2026CNBC

Uber to Invest $1.25 Billion in Rivian for Robotaxi Deployment

Mar 19 2026CNBC

PAVmed to Host Business Update Conference Call

Mar 16 2026PRnewswire

PAVmed to Host Business Update Conference Call

Mar 16 2026Newsfilter

Lucid Diagnostics to Host Business Update Conference Call

Mar 12 2026Newsfilter

Supreme Court Strikes Down Trump's Tariffs, New 15% Levy Announced

Feb 23 2026CNBC

PAVmed Secures $30 Million in Series D Preferred Stock Offering

Feb 04 2026PRnewswire

PAVmed Subsidiary Secures VA Contract for EsoGuard Test, Expanding Access to Over 9 Million Veterans

Jan 22 2026Benzinga